Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
2022 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Shah, S. J; Borlaug, B. A; Chung, E. S; Cutlip, D. E; Debonnaire, P.; Fail, P. S & Gao, Q. et al. (2022)
The Lancet, 399(10330) pp. 1130-1140. DOI: https://doi.org/10.1016/S0140-6736(22)00016-2
